abt-538

Ritonavir (ABT 538) is a peptidomimetic agent that inhibits both HIV-1 and HIV-2 proteases. Ritonavir is highly inhibited by serum proteins but boosts the effect of other HIV proteases by blocking their degradation by cytochrome P450.

Ritonavir-d6 is the deuterated form of Ritonavir. Ritonavir (ABT 538) serves as an inhibitor of the HIV protease, primarily utilized in the study of HIV infection and AIDS. Additionally, Ritonavir acts as an inhibitor of SARS-CoV 3CLpro, with an IC50 of 1.61 μM.

rel-Ritonavir-d6 (rel-ABT 538-d6; rel-RTV-d6) is a deuterated form of Ritonavir. Ritonavir (ABT 538) serves as an inhibitor of HIV protease, utilized in studies of HIV infection and AIDS. Additionally, Ritonavir acts as an inhibitor of SARS-CoV 3CLpro, with an IC50 of 1.61 μM.

Ritonavir (Standard) is a reference standard for research and analysis in studies involving Ritonavir. Ritonavir (ABT 538) is a peptidomimetic agent that inhibits both HIV-1 and HIV-2 proteases. Ritonavir is highly inhibited by serum proteins but boosts the effect of other HIV proteases by blocking their degradation by cytochrome P450.